Outcome of patients aged 60‐75 years with newly diagnosed secondary acute myeloid leukemia: A single‐institution experience

A recent phase 3 trial showed that outcome of older patients with secondary acute myeloid leukemia (AML) may be improved by a liposomal encapsulation of cytarabine and daunorubicin (CPX‐351). This phase 3 study represents a unique example of prospective data in this rare subgroup providing basis for...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertoli, Sarah, Tavitian, Suzanne, Bories, Pierre, Luquet, Isabelle, Delabesse, Eric, Comont, Thibault, Sarry, Audrey, Huguet, Françoise, Bérard, Emilie, Récher, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639188/
https://www.ncbi.nlm.nih.gov/pubmed/31173485
http://dx.doi.org/10.1002/cam4.2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639188/
https://www.ncbi.nlm.nih.gov/pubmed/31173485
http://dx.doi.org/10.1002/cam4.2020

Ejemplares similares